Benjamin Edwards Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Benjamin Edwards Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.28 - $1.16 $2,094 - $8,676	-7,480 Reduced 81.29%	1,722 $1,000
Q1 2024 Apr 29, 2024	BUY	$1.06 - $1.67 $2,471 - $3,894	2,332 Added 33.94%	9,202 $11,000
Q4 2023 Feb 06, 2024	SELL	$1.26 - $1.79 $3,124 - $4,439	-2,480 Reduced 26.52%	6,870 $12,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $2,669 - $4,211	1,658 Added 21.55%	9,350 $17,000
Q2 2023 Aug 15, 2023	BUY	$1.14 - $1.95 $2,023 - $3,461	1,775 Added 30.0%	7,692 $14,000
Q1 2023 Apr 27, 2023	BUY	$1.2 - $2.19 $1,842 - $3,361	1,535 Added 35.03%	5,917 $8,000
Q4 2022 Feb 07, 2023	BUY	$1.63 - $3.52 $2,024 - $4,371	1,242 Added 39.55%	4,382 $7,000
Q3 2022 Oct 28, 2022	SELL	$0.73 - $3.74 $46 - $239	-64 Reduced 2.0%	3,140 $10,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $2,479 - $4,733	1,127 Added 54.26%	3,204 $8,000
Q1 2022 May 04, 2022	BUY	$2.83 - $8.69 $5,877 - $18,049	2,077 New	2,077 $8,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

Stay updated on Benjamin Edwards Inc with notifications on news.